Iran may have supplied Libya with chemical weapons shells

According to U.S. officials, President Obama's administration is currently investigating whether Iran supplied the Libyan government of Muammar Gaddafi with hundreds of special artillery shells for chemical weapons that Libya kept secret for decades.
The shells, which Libya filled with highly toxic mustard agent, were uncovered in recent weeks by revolutionary fighters in central Libya at two separate sites. Both of the sites are under heavy guard and round-the-clock surveillance by drones, Libyan and U.S. officials said, the Washington Post reports.
The discovery of the shells has prompted a U.S. intelligence led probe into how the Libyans obtained them. Several sources said early speculation had fallen on Iran.
A U.S. official with access to classified information confirmed that there were “serious concerns” that Iran had provided Libya with the shells, albeit some years ago, according to the Washington Post. In recent weeks, U.N. inspectors have released new information indicating that Iran has the capacity for developing a nuclear bomb, a charge officials in Iran have long rejected. Confirmed evidence of Iran’s provision of the specialized shells may worsen international tensions over the country’s alleged pursuit of weapons of mass destruction.
One U.S. official said Iran may have sold the shells to Libya after the end of its eight year war with Iraq, in which the Iraqis used nerve and mustard agents against tens of thousands of Iranian troops, the Washington Post reports.
Four diplomatic and American sources said that the shells contain sulfur mustard, popularly known as mustard gas. Mustard gas is a liquid that is rapidly absorbed and causes debilitating respiratory damage and burns. Victims are unaware of their exposure for several hours but then experience swollen eyes, accelerated breathing trouble, widespread blisters, vomiting, nausea, diarrhea and, in severe cases, loss of sight or death. There is no antidote, and recovery, if possible, takes months of skilled medical care.